5HZ9 | pdb_00005hz9

human FABP3 in complex with 6-Chloro-2-methyl-4-phenyl-quinoline-3-carboxylic acid


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 
    0.239 (Depositor), 0.205 (DCC) 
  • R-Value Work: 
    0.197 (Depositor) 
  • R-Value Observed: 
    0.200 (Depositor) 

Starting Model: other
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 5HZ9

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors.

Kuhne, H.Obst-Sander, U.Kuhn, B.Conte, A.Ceccarelli, S.M.Neidhart, W.Rudolph, M.G.Ottaviani, G.Gasser, R.So, S.S.Li, S.Zhang, X.Gao, L.Myers, M.

(2016) Bioorg Med Chem Lett 26: 5092-5097

  • DOI: https://doi.org/10.1016/j.bmcl.2016.08.071
  • Primary Citation Related Structures: 
    5HZ5, 5HZ6, 5HZ8, 5HZ9

  • PubMed Abstract: 

    Dual inhibition of fatty acid binding proteins 4 and 5 (FABP4 and FABP5) is expected to provide beneficial effects on a number of metabolic parameters such as insulin sensitivity and blood glucose levels and should protect against atherosclerosis. Starting from a FABP4 selective focused screening hit, biostructure information was used to modulate the selectivity profile in the desired way and to design potent dual FABP4/5 inhibitors with good selectivity against FABP3. With very good pharmacokinetic properties and no major safety alerts, compound 12 was identified as a suitable tool compound for further in vivo investigations.


  • Organizational Affiliation
    • Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland. Electronic address: holger.kuehne@roche.com.

Macromolecule Content 

  • Total Structure Weight: 127.79 kDa 
  • Atom Count: 9,271 
  • Modeled Residue Count: 1,079 
  • Deposited Residue Count: 1,080 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Fatty acid-binding protein, heart
A, B, C, D, E
A, B, C, D, E, F, G, H
135Homo sapiensMutation(s): 0 
Gene Names: FABP3FABP11MDGI
UniProt & NIH Common Fund Data Resources
Find proteins for P05413 (Homo sapiens)
Explore P05413 
Go to UniProtKB:  P05413
PHAROS:  P05413
GTEx:  ENSG00000121769 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP05413
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
5M8

Query on 5M8



Download:Ideal Coordinates CCD File
DA [auth E]
EA [auth E]
IA [auth F]
L [auth A]
M [auth A]
DA [auth E],
EA [auth E],
IA [auth F],
L [auth A],
M [auth A],
MA [auth G],
N [auth A],
NA [auth G],
OA [auth G],
PA [auth G],
R [auth B],
S [auth B],
SA [auth H],
TA [auth H],
V [auth C],
W [auth C],
Z [auth D]
6-chloranyl-2-methyl-4-phenyl-quinoline-3-carboxylic acid
C17 H12 Cl N O2
DTGFDMHLQGULMA-UHFFFAOYSA-N
SO4

Query on SO4



Download:Ideal Coordinates CCD File
AA [auth E]
BA [auth E]
CA [auth E]
FA [auth F]
GA [auth F]
AA [auth E],
BA [auth E],
CA [auth E],
FA [auth F],
GA [auth F],
HA [auth F],
I [auth A],
J [auth A],
JA [auth G],
K [auth A],
KA [auth G],
O [auth B],
P [auth B],
Q [auth B],
QA [auth H],
T [auth C],
U [auth C],
X [auth D],
Y [auth D]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
CL

Query on CL



Download:Ideal Coordinates CCD File
LA [auth G],
RA [auth H]
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free:  0.239 (Depositor), 0.205 (DCC) 
  • R-Value Work:  0.197 (Depositor) 
  • R-Value Observed: 0.200 (Depositor) 
Space Group: P 43 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 186.827α = 90
b = 186.827β = 90
c = 114.204γ = 90
Software Package:
Software NamePurpose
XSCALEdata scaling
PDB_EXTRACTdata extraction
PHENIXrefinement
XDSdata reduction
REFMACphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2016-12-14
    Type: Initial release
  • Version 1.1: 2024-05-01
    Changes: Data collection, Database references, Refinement description